Atrius India Core FHIR Implementation Guide
0.1.0 - ci-build
Atrius India Core FHIR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://atrius.in/fhir/r4/atrius-in/ActivityDefinition/atrius-ad-med-azithromycin | Version: 0.1.0 | ||||
| Draft as of 2026-07-24 | Computable Name: AtriusMedAzithromycin | ||||
| Other Identifiers: OID:1.3.6.1.4.1.66219.1.11.10 | |||||
Copyright/Legal: © Atrius. Illustrative catalog entry; adapt dosing and formulary to local policy. |
|||||
Azithromycin as the macrolide of choice when the patient is on a statin — negligible CYP3A4 inhibition compared with clarithromycin or erythromycin.
| Metadata | |
|---|---|
| Version | 0.1.0 |
| Identifier | urn:oid:1.3.6.1.4.1.66219.1.11.10 |
| Status | Draft |
| Experimental | true |
| Subject Type | Patient |
| Topic | treatment from http://terminology.hl7.org/CodeSystem/definition-topic |
| Steward (Publisher) | Atrius |
| Steward Contact | Atrius |
| Description | Azithromycin as the macrolide of choice when the patient is on a statin — negligible CYP3A4 inhibition compared with clarithromycin or erythromycin. |
| Copyright | © Atrius. Illustrative catalog entry; adapt dosing and formulary to local policy. |
| Resource Kind | MedicationRequest |
| Resource Profile | Atrius India Core MedicationRequest version: 0.1.0 |
| Intent | Order |
| Product | Azithromycin |
| Dosage | No display for Dosage |
| Generated using version 0.5.4 of the sample-content-ig Liquid templates | |